Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (51-60 of 362) with videos related to

Pageof 37
Sort By:
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse|May 18, 2026
Fernanda Herrera, Pelagia Tsoutsou, Alfredo Addeo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysisUrania Dafni, Zoi Tsourti, Katerina Vervita, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|July 24, 2018
Acceptance of the Advanced Practice Nurse in Lung Cancer Role by Healthcare Professionals and Patients: A Qualitative ExplorationAndrea Serena, Andrew A Dwyer, Solange Peters, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Immune Checkpoint Inhibitors in the Management of Lung CancerStefan Zimmermann, Solange Peters, Taofeek Owinokoko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2019
Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung CancerPablo Martinez, Solange Peters, Timothy Stammers, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.
Cancer Discovery|April 3, 2021
The Promising Evolution of Targeted Therapeutic Strategies in CancerSolange Peters, Tony Mok, Antonio Passaro, et al.
Nature Cancer|February 5, 2022
Overcoming therapy resistance in EGFR-mutant lung cancerAntonio Passaro, Pasi A Jänne, Tony Mok, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Seeking New Approaches to Patients With Small Cell Lung CancerMarie Catherine Pietanza, Stefan Zimmerman, Solange Peters, et al.
Pageof 37

Showing results (51-60 of 362) with videos related to

Sort By:
Pageof 37
ESMO Open|November 5, 2020
Gender-specific aspects of epidemiology, molecular genetics and outcome: lung cancerNuria Mederos, Alex Friedlaender, Solange Peters, et al.
Revue Medicale Suisse|May 18, 2026
Fernanda Herrera, Pelagia Tsoutsou, Alfredo Addeo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2019
Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysisUrania Dafni, Zoi Tsourti, Katerina Vervita, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|July 24, 2018
Acceptance of the Advanced Practice Nurse in Lung Cancer Role by Healthcare Professionals and Patients: A Qualitative ExplorationAndrea Serena, Andrew A Dwyer, Solange Peters, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Immune Checkpoint Inhibitors in the Management of Lung CancerStefan Zimmermann, Solange Peters, Taofeek Owinokoko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2019
Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung CancerPablo Martinez, Solange Peters, Timothy Stammers, et al.
Expert Review of Anticancer Therapy|April 27, 2013
Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectivesJames A Lee, Lukas Bubendorf, Rolf Stahel, et al.
Cancer Discovery|April 3, 2021
The Promising Evolution of Targeted Therapeutic Strategies in CancerSolange Peters, Tony Mok, Antonio Passaro, et al.
Nature Cancer|February 5, 2022
Overcoming therapy resistance in EGFR-mutant lung cancerAntonio Passaro, Pasi A Jänne, Tony Mok, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Seeking New Approaches to Patients With Small Cell Lung CancerMarie Catherine Pietanza, Stefan Zimmerman, Solange Peters, et al.
Pageof 37